Cite
APA Citation
Rapoport, B., Schwartzberg, L., Chasen, M., Powers, D., Arora, S., Navari, R., & Schnadig, I. (2016). efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy. European journal of cancer, 57, 23–30. http://access.bl.uk/ark:/81055/vdc_100030957025.0x00005a